BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1572348)

  • 1. Mutagenicity of benzo(a)pyrenyl-1-sulfate in the Ames test.
    Irwin SE; Kwei GY; Blackburn GR; Thurman R; Kauffman FC
    Environ Mol Mutagen; 1992; 19(3):253-8. PubMed ID: 1572348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
    Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic activity of biliary metabolites of 6-hydroxymethylbenzo[a]pyrene.
    Hughes MF; Kadry AR; Gairola CG; Flesher JW
    Mutat Res; 1986 Apr; 173(4):251-6. PubMed ID: 3513004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte-mediated mutagenicity of mononitrobenzo[a]pyrenes in Salmonella typhimurium strains.
    Hass BS; Heflich RH; Chou MW; White GL; Fu PP; Casciano DA
    Mutat Res; 1986; 171(2-3):123-9. PubMed ID: 3528834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excretion of 3-hydroxy-benzo(a)pyrene and mutagenicity in rat urine after exposure to benzo(a)pyrene.
    Jongeneelen FJ; Leijdekkers CM; Bos RP; Theuws JL; Henderson PT
    J Appl Toxicol; 1985 Oct; 5(5):277-82. PubMed ID: 3902943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity and cytotoxicity of benzo(a)pyrene arene oxides, phenols, quinones, and dihydrodiols in bacterial and mammalian cells.
    Wislocki PG; Wood AW; Chang RL; Levin W; Yagi H; Hernandez O; Dansette PM; Herina DM; Conney AH
    Cancer Res; 1976 Sep; 36(9 pt.1):3350-7. PubMed ID: 788898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of mutagenic metabolites of benzo[a]pyrene from the perfused rat liver after inhibition of glucuronidation and sulfation by salicylamide.
    Bock KW; Bock-Hennig BS; Lilienblum W; Volp RF
    Chem Biol Interact; 1981 Aug; 36(2):167-77. PubMed ID: 6268312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenium inhibition of benzo[a]pyrene, 3-methylcholanthrene, and 3-methylcholanthrylene mutagenicity in Salmonella typhimurium strains TA98 and TA100.
    Prasanna P; Jacobs MM; Yang SK
    Mutat Res; 1987 Feb; 190(2):101-5. PubMed ID: 3547113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
    Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
    Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenicity and co-mutagenicity of catechol on Salmonella.
    Yoshida D; Fukuhara Y
    Mutat Res; 1983 Apr; 120(1):7-11. PubMed ID: 6339915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity and in vivo disposition of biliary metabolites of benzo(a)pyrene.
    Chipman JK; Millburn P; Brooks TM
    Toxicol Lett; 1983 Jul; 17(3-4):233-40. PubMed ID: 6312638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat nasal tissue activation of benzo(a)pyrene and 2-aminoanthracene to mutagens in Salmonella typhimurium.
    Bond JA; Li AP
    Environ Mutagen; 1983; 5(3):311-8. PubMed ID: 6303770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenium modified mutagenicity and metabolism of benzo[a]pyrene in an S9-dependent system.
    Teel RW; Kain SR
    Mutat Res; 1984 Jun; 127(1):9-14. PubMed ID: 6328289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the effect of selenium on the mutagenicity and metabolism of benzo[a]pyrene in rat and hamster liver S9 activation systems.
    Teel RW
    Cancer Lett; 1984 Oct; 24(3):281-9. PubMed ID: 6388822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxicity of apomorphine and various catecholamines in the Salmonella mutagenicity test (Ames test) and in tests for primary DNA damage using DNA repair-deficient B. subtilis strains (rec assay).
    Suter W; Matter-Jaeger I
    Mutat Res; 1984 Jul; 137(1):17-28. PubMed ID: 6431280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promutagen activation with mammalian and avian S9 liver microsomes.
    Tometsko AM; Sheridan KM; DeTraglia MC
    J Appl Toxicol; 1981 Feb; 1(1):11-4. PubMed ID: 6309943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test-condition-dependent influence of harman and nonharman on benzo[a]pyrene mutagenesis in Salmonella.
    Riebe M; Westphal K; Keller H
    Mutat Res; 1982 Apr; 104(1-3):9-15. PubMed ID: 7043258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mutagenicity of mixtures of halogenated aliphatic hydrocarbons and polycyclic aromatic hydrocarbons in the Ames test with TA98 and TA100].
    Kevekordes S; Porzig J; Gebel T; Dunkelberg H
    Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):531-41. PubMed ID: 9531725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.